Shorts

Building Trust in Clinical Trials for Oncology: Amir Fathi, MD

Why Clinical Trials Are the Key to Beating Cancer: Amir Fathi, MD

How Academic Centers Can Support Community Hospitals: Andrew Yee, MD

Understanding the 3 Pillars of CRC Prevention: Jordan Karlitz, MD

Psoriasis Is More Than Just Skin Deep: James Song, MD

Is Your Genetic Risk a Piece of a Larger Puzzle? David Zhang, MD

Why New Cancer Treatments Widen the Inequity Gap: Sarah M. Lima, PhD, MPH

Future Legislation Will Need to Continue to Address Hidden Fees from PBMs, Make Fees More Transparent: Miriam Paramore

Whole-Genome Sequencing Clarifies Genetic Risk in IPF: David Zhang, MD

Why Zip Code Still Affects Cancer Survival: Sarah M. Lima, PhD, MPH

Why Independent Pharmacies Can't See Real Drug Costs: Miriam Paramore

Detecting Cancer Resistance Early via Liquid Biopsies: Ateequllah Hayat, PhD

How Breast Cancer Cells "Hide" From Treatment: Ateequllah Hayat, PhD

Why 100% Skin Clearance Is Not Always Enough: James Song, MD

PBM Reform Hinges on Making Prices Transparent for All: Miriam Paramore

Advanced Multiple Myeloma Therapies Require Dedicated Teams, 24/7 Support for Safe Patient Care: Ameet Patel, MD

Access, Geography, and Cost Limit Patient Participation in Clinical Trials: Susan Vadaparampil, PhD, MPH

How Successful Medically Integrated Dispensing Works in Practice: Kenneth Komorny, PharmD, BCPS

Weighing the Pros, Cons of Medically Integrated Dispensing: Katherine Tobon, PharmD, BCOP

Strengthening Trial Infrastructure to Broaden Patient Access: Tina Bhatnagar, DO

Restoring the Optic Nerve a Primary Goal in the Future of Glaucoma Treatment: Ariana Levin, MD

Glaucoma Seeing Emerging Therapies in Eye Drops, Surgery Modalities: Jullia Rosdahl, MD, PhD

Catching Glaucoma Early Relies on Consistent Testing With Eye Doctors: Ariana Levin, MD

Closing Data Gaps in Precision Oncology: Tina Bhatnagar, DO

Glaucoma Can Be Mitigated Through Screening Those at Highest Risk: Manjool Shah, MD

Increased Influenza Hospitalizations Underscore the Need for Stronger Prevention Strategies: Marco del Riccio, MD

Laser, Eye Drops Are First-Line Treatment for Glaucoma: Jullia Rosdahl, MD, PhD

Integrated, Age-Specific Care Is Essential for Young Patients With Breast Cancer: Yara Abdou, MD

Glaucoma Known as the "Silent Thief" of Vision: Manjool Shah, MD

Patient–Investigator Collaboration Drives Health Care Innovation: Debra Patt, MD, PhD, MBA, MPH